calcipotriene and Urinary-Bladder-Neoplasms

calcipotriene has been researched along with Urinary-Bladder-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for calcipotriene and Urinary-Bladder-Neoplasms

ArticleYear
[Acanthosis nigricans associated with transitional cell carcinoma of the bladder--symptomatic treatment with calcipotriol].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1999, Volume: 50, Issue:8

    Acanthosis nigricans is a hyperkeratotic mucocutaneous eruption of heterogenous etiology which is characterized by hyperpigmentation, velvety cutaneous thickening, intensified skin markings and development of verrucous excrescences typically involving the intertriginous areas. Malignant acanthosis nigricans is most often associated with an abdominal adenocarcinoma frequently unresectable at the time of diagnosis. We report on the rare association of acanthosis nigricans with a transitional cell carcinoma of the urinary bladder. Symptomatic treatment with topical calcipotriol significantly reduced the hyperkeratotic and papillomatous skin changes.

    Topics: Acanthosis Nigricans; Administration, Topical; Antineoplastic Agents; Calcitriol; Carcinoma, Transitional Cell; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Skin; Treatment Outcome; Urinary Bladder Neoplasms

1999